soma chems retatrutide Peptides RETATRUTIDE | 2381089-83-2
Description
A.FreitasT
R., LeMoine, F
Mounjaro, approved for type 2 diabetes)
Effects: Dizziness, lightheadedness, or low blood pressure
The most commonly reported side effects are mild and transient, including injection site reactions (redness, slight swelling, or tenderness), mild headaches during the initial days of use, and occasional dizziness or lightheadedness, particularly when starting the peptide
